Skip to Main Content

Author Details

George Steven Bova
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
1982
120
60
PMIDPaper TitleJournal TitlePublished Year
37140987Identification of long noncoding RNAs with aberrant expression in prostate cancer metastases.Endocr Relat Cancer2023
38023254Fanconi anemia pathway regulation by FANCI in prostate cancer.Front Oncol2023
37828555Cancer origin tracing and timing in two high-risk prostate cancers using multisample whole genome analysis: prospects for personalized medicine.Genome Med2023
35131885The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource.Cancer Epidemiol Biomarkers Prev2022
33211668Generalized Fixation Invariant Nuclei Detection Through Domain Adaptation Based Deep Learning.IEEE J Biomed Health Inform2021
34348967Subclone Eradication Analysis Identifies Targets for Enhanced Cancer Therapy and Reveals L1 Retrotransposition as a Dynamic Source of Cancer Heterogeneity.Cancer Res2021
34337548Combined Longitudinal Clinical and Autopsy Phenomic Assessment in Lethal Metastatic Prostate Cancer: Recommendations for Advancing Precision Medicine.Eur Urol Open Sci2021
33033260Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy.Nat Commun2020
28984675Feasibility of Prostate PAXgene Fixation for Molecular Research and Diagnostic Surgical Pathology: Comparison of Matched Fresh Frozen, FFPE, and PFPE Tissues.Am J Surg Pathol2018
29988112Constitutively active androgen receptor splice variants AR-V3, AR-V7 and AR-V9 are co-expressed in castration-resistant prostate cancer metastases.Br J Cancer2018
29728311Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.Pathol Res Pract2018
29662167Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.Nat Genet2018
28783720Cancer genomics: Human metastases under scrutiny.Nature2017
29269934The expression of AURKA is androgen regulated in castration-resistant prostate cancer.Sci Rep2017
28945760Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data.PLoS Genet2017
26939004Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.PLoS One2016
26652980Resolving complex research data management issues in biomedical laboratories: Qualitative study of an industry-academia collaboration.Comput Methods Programs Biomed2016
27615322Mutational signatures of ionizing radiation in second malignancies.Nat Commun2016
27148588Integrated clinical, whole-genome, and transcriptome analysis of multisampled lethal metastatic prostate cancer.Cold Spring Harb Mol Case Stud2016
27197245Corrigendum: Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.Genome Res2016
25963125Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells.Genome Res2015
25830880The evolutionary history of lethal metastatic prostate cancer.Nature2015
25082706Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes.Science2014
25271376Origins and functional consequences of somatic mitochondrial DNA mutations in human cancer.Elife2014
23144336Longitudinal analysis of pain in patients with metastatic prostate cancer using natural language processing of medical record text.J Am Med Inform Assoc2013
24289299Epithelium percentage estimation facilitates epithelial quantitative protein measurement in tissue specimens.Clin Proteomics2013
24083995Loss of PTEN is associated with aggressive behavior in ERG-positive prostate cancer.Cancer Epidemiol Biomarkers Prev2013
23636849Somatic alterations contributing to metastasis of a castration-resistant prostate cancer.Hum Mutat2013
23609948Genetic markers associated with early cancer-specific mortality following prostatectomy.Cancer2013
23716368Identification, prioritization, and evaluation of glycoproteins for aggressive prostate cancer using quantitative glycoproteomics and antibody-based assays on tissue specimens.Proteomics2013
23359150Optimal molecular profiling of tissue and tissue components: defining the best processing and microdissection methods for biomedical applications.Methods Mol Biol2013
23345608DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.Sci Transl Med2013
22139082Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer.Oncogene2012
25419216Clustering-Based Method for Developing a Genomic Copy Number Alteration Signature for Predicting the Metastatic Potential of Prostate Cancer.J Probab Stat2012
22357564High-content screening data management for drug discovery in a small- to medium-size laboratory: results of a collaborative pilot study focused on user expectations as indicators of effectiveness.J Lab Autom2012
21248069Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression.Cancer Res2011
21780747Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer.Anal Chem2011
21975078Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosorbent assays.Anal Chem2011
21946329A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancer.Epigenetics2011
21498400BACOM: in silico detection of genomic deletion types and correction of normal cell contamination in copy number data.Bioinformatics2011
20124447Loss of Kelch-like ECH-associated protein 1 function in prostate cancer cells causes chemoresistance and radioresistance and promotes tumor growth.Mol Cancer Ther2010
20601956Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements.Nat Genet2010
20192651Disseminated intravascular coagulation associated with ventriculoperitoneal shunt surgery.J Neurosurg Pediatr2010
19142959Comprehensive mutational analysis and mRNA isoform quantification of TP63 in normal and neoplastic human prostate cells.Prostate2009
19363497Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.Nat Med2009
19117982Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer.Cancer Res2009
18302221Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues.Prostate2008
18974140DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity.Cancer Res2008
18327244Minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE).Nat Biotechnol2008
17909025Roles for the stem cell associated intermediate filament Nestin in prostate cancer migration and metastasis.Cancer Res2007
  • 1 - 50 of 120

Recommended Authors

Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 8
Anne Haegert
University of British Columbia
Career Start Year 2008
Number of shared co-authors 9
Mark M Pomerantz
Dana-Farber Cancer Institute
Career Start Year 2007
Number of shared co-authors 28
Tamara L Lotan
Johns Hopkins University School of Medicine
Career Start Year 2006
Number of shared co-authors 35
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 2
Thorsten Schlomm
Charite - University Hospital Berlin
Career Start Year 2004
Number of shared co-authors 25
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 8
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 29
Adam Foye
University of California San Francisco
Career Start Year 2003
Number of shared co-authors 12
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 12
Erich Jaeger
Illumina Inc.
Career Start Year 2001
Number of shared co-authors 7
Ilsa Coleman
Fred Hutchinson Cancer Center
Career Start Year 2001
Number of shared co-authors 27
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 17
Xuhong Cao
Michigan Center for Translational Pathology.
Career Start Year 1999
Number of shared co-authors 10
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 11
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 8
Volker Jung
Clinic of Urology and Pediatric Urology, University of Saarland
Career Start Year 1994
Number of shared co-authors 1
Arul M Chinnaiyan
University of Michigan Medical School.
Career Start Year 1993
Number of shared co-authors 34
Peter S Nelson
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 39
Penny Flohr
The Institute of Cancer Research
Career Start Year 1993
Number of shared co-authors 30
Rosina T Lis
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 14
Guido Jenster
Erasmus University Medical Center
Career Start Year 1990
Number of shared co-authors 32
Suzanne Carreira
The Institute of Cancer Research
Career Start Year 1990
Number of shared co-authors 15
Gyorgy Petrovics
Henry Jackson Foundation for the Advancement of Military Medicine (HJF)
Career Start Year 1990
Number of shared co-authors 21
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 28
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 16
Colin C Collins
University of British Columbia
Career Start Year 1988
Number of shared co-authors 22
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 37
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1981
Number of shared co-authors 25
Francesca Demichelis
University of Trento
Career Start Year 1969
Number of shared co-authors 19

Collaborators

William B Isaacs
The Brady Urological Institute, The Johns Hopkins School of Medicine
Co-authored papers 63
Tapio Visakorpi
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 18
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 12
Jianfeng Xu
Co-authored papers 11
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Co-authored papers 9
Ultan McDermott
Wellcome Sanger Institute
Co-authored papers 8
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Co-authored papers 8
David E Neal
University of Oxford, John Radcliffe Hospital
Co-authored papers 7
Colin S Cooper
Norwich Medical School, University of East Anglia
Co-authored papers 7
Christopher S Foster
The Institute of Cancer Research
Co-authored papers 7
Rosalind A Eeles
The Institute of Cancer Research
Co-authored papers 7
Michael R Emmert-Buck
The Francis Crick Institute
Co-authored papers 6
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Co-authored papers 6
Daniel S Brewer
University of Washington, USA Institute for Stem Cell and Regenerative Medicine
Co-authored papers 6
Henrik Gr??nberg
Karolinska Institute
Co-authored papers 6
Peter J Campbell
Wellcome Sanger Institute
Co-authored papers 6
John D Carpten
Co-authored papers 6
Peter Van Loo
The Francis Crick Institute
Co-authored papers 6
Ludmil B Alexandrov
Moores Cancer Center, university of california san diego
Co-authored papers 5
Patrick S Tarpey
Wellcome Trust Sanger Institute
Co-authored papers 5
Adrienne M Flanagan
University College London, UCL Cancer Institute
Co-authored papers 5
Deborah A Meyers
Co-authored papers 5
Matti Annala
University of British Columbia
Co-authored papers 5
Manasa Ramakrishna
Co-authored papers 5
Adam Butler
Wellcome Sanger Institute
Co-authored papers 5
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Co-authored papers 5
Hayley C Whitaker
University College London
Co-authored papers 5
Sinja Taavitsainen
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 5
Serena Nik-Zainal
Early Cancer Institute, University of Cambridge
Co-authored papers 5
Keiran Raine
Wellcome Sanger Institute
Co-authored papers 4
Release 1.2